<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001210.v1.p1" parentStudy="phs001210.v1.p1" createDate="2016-09-12" modDate="2016-09-12">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Curtis C. Harris</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Stephen J. Chanock</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Melinda Aldrich</td><td>Vanderbilt University Medical Center, Nashville, TN, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Christopher I. Amos</td><td>Geisel School of Medicine, Lebanon, NH, USA</td></tr>
		<tr><td>Co-Investigator</td><td>William J. Blot</td><td>Vanderbilt University Medical Center, Nashville, TN, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NCI Lung Cancer and Smoking Phenotypes in African-American Subjects</StudyNameEntrez>
	<StudyNameReportPage>National Cancer Institute (NCI) Study of Lung Cancer and Smoking Phenotypes in African-American Cases and Controls</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Longitudinal Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This is a two-stage case-control study designed to evaluate the association between common genetic variants and the risk of lung cancer. The stage 1 studies included 1737 cases and 3602 controls from the following studies: MD Anderson Lung Cancer Epidemiology Study, The Multiethnic Cohort Study (MEC), NCI-MD Lung Cancer-Case Control Study, Northern California Lung Cancer Study, Project CHURCH (Creating a Higher Understanding of Cancer Research &#948; Community Health), Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), Southern Community Cohort Study (SCCS), and the Karmanos Cancer Institute at Wayne State University (KCI/WSU). The stage 2 studies included an independent set of 866 cases and 796 controls from the following studies: The Black Women&#39;s Health Study (BWHS), The Harvard-MGH Lung Cancer Susceptibility Study (HLCS), MD Anderson Lung Cancer Epidemiology Study, MD Anderson/LBJ Hospital Biorepository, NCI-MD Lung Cancer Case-Control Study, Northern California Lung Cancer Study, Philadelphia Lung Cancer Study on Gene Environment Interactions (Plus-Gene), Southern Community Cohort Study (SCCS), and KCI/WSU.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Each study had specific inclusion and exclusion criteria to that study</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="27393504"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Lung Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Curtis C. Harris</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Stephen J. Chanock</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Lead Investigator">
			<AttName>Krista A. Zanetti</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Lead Investigator">
			<AttName>Zhaoming Wang</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Melinda Aldrich</AttName>
			<Institution>Vanderbilt University Medical Center, Nashville, TN, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Christopher I. Amos</AttName>
			<Institution>Geisel School of Medicine, Lebanon, NH, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>William J. Blot</AttName>
			<Institution>Vanderbilt University Medical Center, Nashville, TN, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Elise D. Bowman</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Laurie Burdette</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Qiuyan Cai</AttName>
			<Institution>Vanderbilt University Medical Center, Nashville, TN, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Neil Caporaso</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Charles C. Chung</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Elizabeth M. Gillanders</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Christopher A. Haiman</AttName>
			<Institution>University of Southern California and Norris Comprehensive Cancer Center, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Helen M. Hansen</AttName>
			<Institution>University of California, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Brian E. Henderson</AttName>
			<Institution>University of Southern California and Norris Comprehensive Cancer Center, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Laurence N. Kolonel</AttName>
			<Institution>University of Hawaii, Honolulu, HI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Loic Le Marchand</AttName>
			<Institution>University of Hawaii, Honolulu, HI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Shegchao Li</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Lorna Houghton McNeill</AttName>
			<Institution>The University of Texas MD Anderson Cancer Center, Houston, TX, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Brid M. Ryan</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Ann G. Schwartz</AttName>
			<Institution>Wayne State University School of Medicine, Detroit, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Jennette D. Sison</AttName>
			<Institution>University of California, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Margaret R. Spitz</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Margaret Tucker</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Angela S. Wenzlaff</AttName>
			<Institution>Wayne State University School of Medicine, Detroit, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>John K. Wiencke</AttName>
			<Institution>University of California, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Lynne Wilkens</AttName>
			<Institution>University of Hawaii, Honolulu, HI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Margaret R. Wrensch</AttName>
			<Institution>University of California, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Xifeng Wu</AttName>
			<Institution>The University of Texas MD Anderson Cancer Center, Houston, TX, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Wei Zheng</AttName>
			<Institution>Vanderbilt University Medical Center, Nashville, TN, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Weiyin Zhou</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CA" longName="Disease-Specific (Cancer)"/>
		<ConsentGroup groupNum="2" shortName="GRU" longName="General Research Use"/>
		<ConsentGroup groupNum="3" shortName="GRU-IRB" longName="General Research Use (IRB)"/>
		<ConsentGroup groupNum="4" shortName="DS-CA-PUB-NPU-RD" longName="Disease-Specific (Cancer, PUB, NPU, RD)"/>
		<ConsentGroup groupNum="5" shortName="DS-CA-MDS" longName="Disease-Specific (Cancer, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs001210.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001210.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001210.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Cancer)</ConsentName>
        <ConsentAbbrev>DS-CA</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="2">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="3">
        <ConsentName>General Research Use (IRB)</ConsentName>
        <ConsentAbbrev>GRU-IRB</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Requestor must provide documentation of local IRB approval.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="4">
        <ConsentName>Disease-Specific (Cancer, PUB, NPU, RD)</ConsentName>
        <ConsentAbbrev>DS-CA-PUB-NPU-RD</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer and related disorders.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="5">
        <ConsentName>Disease-Specific (Cancer, MDS)</ConsentName>
        <ConsentAbbrev>DS-CA-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
